Skip to main content

Depo Provera

Volume 167: debated on Wednesday 14 February 1990

The text on this page has been created from Hansard archive content, it may contain typographical errors.

To ask the Secretary of State for Health whether the contraceptive drug Depo Provera is approved for use in the United Kingdom; and if he will make a statement.

Depo Provera is licensed in the United Kingdom for use in short-term contraception where an oral contraceptive is contraindicated or considered inappropriate, for wives of men undergoing vasectomy and for women being immunised against rubella; it is also licensed for long-term use in women for whom other contraceptives are contraindicated or have caused unacceptable side-effects. In addition, the product is licensed for the treatment of endometriosis, and of certain malignant tumours.